Last updated: 2026-09-29 11:35:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ALPS Group Inc. (ALPS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.41, with a market capitalization of $66.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.23 to $2.90. This page covers its latest market performance, valuation, price trends and company information.
$66.56M | |
$0.40 | |
$6.18 | |
$0.14 | |
$0.40 | |
2.02K | |
127.54K | |
-- | |
$2.90 | |
$0.23 | |
-- | |
-- |
ALPS Group Inc. (ALPS) is trading at $0.41 in pre-market trading as of 2026-09-29 11:02:00, up 2.50% ($0.01) from the previous close of $0.40
Pre-market trading shows how investors are pricing ALPS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, ALPS Group Inc. (ALPS) moved from $0.40 to $0.41, representing a gain of 2.50% ($0.01).
The stock traded between $0.37 and $0.41 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 65.28 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 6.8%
ALPS is currently trading at $0.41, placing it 6.8% of the way from its 52-week low of $0.23 to its 52-week high of $2.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.
| Employees | 89 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ALPS Group Inc. (ALPS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.